Actrapid and Chronic kidney disease - a phase IV clinical study of FDA data

Summary:

Chronic kidney disease is reported as a side effect among people who take Actrapid (insulin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Magnesium, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Chronic kidney disease when taking Actrapid. It is created by eHealthMe based on reports of 4,843 people who have side effects when taking Actrapid from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Chronic kidney disease?

Chronic kidney disease is found to be associated with 1,824 drugs and 1,364 conditions by eHealthMe. Check the latest studies of Chronic kidney disease.

On Jul, 09, 2026

4,843 people reported to have side effects when taking Actrapid.
Among them, 15 people (0.31%) have Chronic kidney disease.

Could Actrapid cause Chronic kidney disease?

Among these 15 people:

How long have people been on Actrapid when they have Chronic kidney disease? *

What is the gender of people who have Chronic kidney disease when taking Actrapid? *

female: 60 %
male: 40 %

What is the age of people who have Chronic kidney disease when taking Actrapid? *

What are other drugs people take besides Actrapid? *

What are other side effects people have besides Chronic kidney disease? *

Cardiac Failure: 5 people, 33.33%
Anuria (failure of the kidneys to produce urine): 5 people, 33.33%
Hyperkalemia (damage to or disease of the kidney): 5 people, 33.33%
Lactic Acidosis (low ph in body tissues): 5 people, 33.33%
General Physical Health Deterioration (weak health status): 4 people, 26.67%
Weakness: 4 people, 26.67%
Tendon Rupture (tear of tendon): 3 people, 20.00%
Pneumonia: 3 people, 20.00%
High Blood Pressure: 3 people, 20.00%
Urinary Retention (the inability to completely or partially empty the bladder): 3 people, 20.00%

What are the existing conditions these people have? *

Type 2 Diabetes: 7 people, 46.67%
High Blood Pressure: 6 people, 40.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 20.00%
Anaemia (lack of blood): 2 people, 13.33%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 13.33%
Rashes (redness): 2 people, 13.33%
Diabetes: 2 people, 13.33%
Cardiac Failure: 2 people, 13.33%
Cardiomyopathy (weakening of the heart muscle): 1 person, 6.67%
Dyspnea (difficult or laboured breathing): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and have Chronic kidney disease?

- Check whether Chronic kidney disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actrapid:

Actrapid (4,864 reports)

Browse all side effects of Actrapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic kidney disease:

Chronic kidney disease (1,824 drugs)

Browse all the conditions that are associated with Chronic kidney disease:

Chronic kidney disease (1,364 conditions)

Related publications that referenced our studies

Aalaei-Andabili, S. H., Umer, M., & Keeley, E. C., "An Adult Woman With Stage 4 Chronic Kidney Disease and a Diffuse Rash", JAMA cardiology, 2019 Jan .
Aalaei-Andabili, S. H., Umer, M., & Keeley, E. C., "An Adult Woman With Stage 4 Chronic Kidney Disease and a Diffuse Rash", JAMA cardiology, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on insulin (the active ingredients of Actrapid) and Actrapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.